Gentulizumab

DRUG2 trials

Sponsors

Changchun GeneScience Pharmaceutical Co., Ltd.

Conditions

Acute Myelogenous LeukemiaMyelodysplastic SyndromesNon-Hodgkin LymphomaSolid Tumor

Phase 1

Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma

TerminatedNCT05221385

Changchun GeneScience Pharmaceutical Co., Ltd.Non-Hodgkin Lymphoma, Solid Tumor

Start: 2021-04-12End: 2023-10-27Updated: 2023-11-07

Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome

TerminatedNCT05263271

Changchun GeneScience Pharmaceutical Co., Ltd.Acute Myelogenous Leukemia, Myelodysplastic Syndromes

Start: 2021-04-01End: 2024-12-18Updated: 2026-04-06